↓ Skip to main content

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate

Overview of attention for article published in BMC Medicine, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
7 news outlets
twitter
110 X users
facebook
4 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user
reddit
1 Redditor
video
1 YouTube creator

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
Published in
BMC Medicine, January 2016
DOI 10.1186/s12916-016-0550-5
Pubmed ID
Authors

FD Richard Hobbs, Maciej Banach, Dimitri P. Mikhailidis, Aseem Malhotra, Simon Capewell

Abstract

The most prescribed medications in the world are statins, lipid modifiers that have been available for over 25 years and amongst the most investigated of all drug classes. With over a million patient years of trial data and publications in the most prestigious medical journals, it is remarkable that quite so much debate remains as to their place in healthcare. They have had a bittersweet passage, with vocal concerns over their possible risks, from suicide to cancer, and allegations that they do not work in women or the elderly, to statements that the whole published dataset, on over 200,000 patients consenting to enter trials, was fatally compromised by being industry-funded by and large. On the other side, there have been billions of dollars spent on generating their evidence base followed by promotion which has returned that investment many times over in profits, and a powerful scientific lobby that argue they are wonder drugs and that continued nihilism on their value risks patient lives. So who is right?

X Demographics

X Demographics

The data shown below were collected from the profiles of 110 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
United States 1 <1%
Unknown 99 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 14%
Other 11 11%
Student > Master 11 11%
Student > Bachelor 8 8%
Student > Ph. D. Student 8 8%
Other 25 25%
Unknown 24 24%
Readers by discipline Count As %
Medicine and Dentistry 36 36%
Biochemistry, Genetics and Molecular Biology 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Nursing and Health Professions 4 4%
Unspecified 4 4%
Other 14 14%
Unknown 29 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 123. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2023.
All research outputs
#338,091
of 25,389,532 outputs
Outputs from BMC Medicine
#279
of 4,005 outputs
Outputs of similar age
#5,914
of 402,573 outputs
Outputs of similar age from BMC Medicine
#5
of 53 outputs
Altmetric has tracked 25,389,532 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,005 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 402,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.